Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
126
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $127M | 0.08% |
1,035,674
+145,773
| +16% | +$17.9M |
|
127
Winnebago Industries
WGO
$906M
| $124M | 0.08% |
1,707,422
-43,362
| -2% | -$3.03M |
|
128
Paycom
PAYC
$8.13B
| $124M | 0.08% |
249,417
+10,953
| +5% | +$4.88M |
|
129
West Pharmaceutical
WST
$24.6B
| $120M | 0.07% |
283,118
-4,624
| -2% | -$1.95M |
|
130
Blackrock
BLK
$175B
| $120M | 0.07% |
142,518
+2,166
| +2% | +$1.94M |
|
131
Qorvo
QRVO
$8.4B
| $119M | 0.07% |
711,772
+22,394
| +3% | +$4.16M |
|
132
MSCI
MSCI
$41.4B
| $119M | 0.07% |
195,133
+765
| +0.4% | +$467K |
|
133
Darling Ingredients
DAR
$9.34B
| $117M | 0.07% |
1,626,967
-50,878
| -3% | -$3.64M |
|
134
Meritage Homes
MTH
$4.88B
| $116M | 0.07% |
2,390,198
-66,334
| -3% | -$3.42M |
|
135
Itaú Unibanco
ITUB
$91.8B
| $114M | 0.07% |
29,732,360
-1,685,896
| -5% | -$6.9M |
|
136
Pool Corp
POOL
$7.46B
| $113M | 0.07% |
259,289
-7,539
| -3% | -$3.57M |
|
137
State Street Industrial Select Sector SPDR ETF
XLI
$34B
| $111M | 0.07% |
1,136,771
+49,181
| +5% | +$5.05M |
|
138
Raymond James Financial
RJF
$34.7B
| $109M | 0.07% |
1,183,897
+649
| +0.1% | +$58.1K |
|
139
Bio-Rad Laboratories Class A
BIO
$9.28B
| $109M | 0.07% |
145,815
-2,337
| -2% | -$1.75M |
|
140
iShare MSCI Eurozone ETF
EZU
$9.85B
| $108M | 0.07% |
2,245,450
+139,955
| +7% | +$7M |
|
141
Johnson & Johnson
JNJ
$622B
| $108M | 0.07% |
666,116
+1,645
| +0.2% | +$281K |
|
142
Pfizer
PFE
$145B
| $105M | 0.07% |
2,444,296
-2,276
| -0.1% | -$101K |
|
143
ScottsMiracle-Gro
SMG
$3.86B
| $104M | 0.06% |
713,833
-14,388
| -2% | -$2.36M |
|
144
Steris
STE
$22.4B
| $104M | 0.06% |
510,721
-7,270
| -1% | -$1.56M |
|
145
Global Payments
GPN
$24.3B
| $103M | 0.06% |
651,087
-5,631
| -0.9% | -$978K |
|
|
MRO
146
DELISTED
Marathon Oil Corporation
MRO
| $102M | 0.06% |
7,458,741
+104,846
| +1% | +$1.26M |
|
147
Procter & Gamble
PG
$341B
| $102M | 0.06% |
728,999
+24,399
| +3% | +$3.46M |
|
148
Semtech
SMTC
$11.5B
| $101M | 0.06% |
1,291,217
-10,514
| -0.8% | -$720K |
|
149
Charles River Laboratories
CRL
$12.5B
| $100M | 0.06% |
243,141
+7,909
| +3% | +$3.28M |
|
150
Helen of Troy
HELE
$687M
| $99.9M | 0.06% |
444,770
-14,011
| -3% | -$3.21M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.